KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Virgin Galactic Holdings (SPCE) Cash & Equivalents (2017 - 2025)

Historic Cash & Equivalents for Virgin Galactic Holdings (SPCE) over the last 9 years, with Q3 2025 value amounting to $128.8 million.

  • Virgin Galactic Holdings' Cash & Equivalents fell 2527.86% to $128.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $128.8 million, marking a year-over-year decrease of 2527.86%. This contributed to the annual value of $178.6 million for FY2024, which is 1761.72% down from last year.
  • According to the latest figures from Q3 2025, Virgin Galactic Holdings' Cash & Equivalents is $128.8 million, which was down 2527.86% from $163.5 million recorded in Q2 2025.
  • In the past 5 years, Virgin Galactic Holdings' Cash & Equivalents registered a high of $702.6 million during Q3 2021, and its lowest value of $128.8 million during Q3 2025.
  • Moreover, its 5-year median value for Cash & Equivalents was $302.3 million (2022), whereas its average is $337.2 million.
  • In the last 5 years, Virgin Galactic Holdings' Cash & Equivalents skyrocketed by 5326.64% in 2021 and then tumbled by 5298.5% in 2024.
  • Quarter analysis of 5 years shows Virgin Galactic Holdings' Cash & Equivalents stood at $524.5 million in 2021, then plummeted by 42.36% to $302.3 million in 2022, then decreased by 28.28% to $216.8 million in 2023, then fell by 17.62% to $178.6 million in 2024, then dropped by 27.89% to $128.8 million in 2025.
  • Its Cash & Equivalents was $128.8 million in Q3 2025, compared to $163.5 million in Q2 2025 and $140.8 million in Q1 2025.